Article
Elucidating Genetic and Immunological Pathways Mediated by Sodium-Glucose Transporter 2 Inhibitors in Reducing Gout Risk: A Two-Step Mendelian Randomization Study.
Assay and drug development technologies - 1 Jan 2025
Zeng Huiqiong, Cai Zebo, Lai Junda, Chen Zhijun, Liu Wei, Zhang Ye
Abstract excerpt
While sodium-glucose transporter 2 inhibitors (SGLT2i) demonstrate urate-lowering effects, their causal role in Gout prevention remains controversial. This study employs advanced Mendelian randomization (MR) techniques to dissect immune-mediated mechanisms underlying this relationship. Using bidirectional two-sample MR and mediation analysis, we analyzed genetic instrument variables for SGLT2i (10...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
